+96.7%
ELAN vs IVZ
+134.7%
-38.0%
-56.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | IVZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.4% | +1.1% | +0.3% | +0.9% |
| 7D | -5.4% | -2.4% | -3.0% | -4.4% |
| 30D | +4.7% | +3.0% | +1.7% | +3.3% |
| 3M | -3.7% | +14.9% | -18.5% | -10.3% |
| 6M | -1.2% | +36.7% | -37.9% | -15.3% |
| YTD | +2.4% | +25.7% | -23.3% | -9.3% |
| 1Y | +23.4% | +47.7% | -24.3% | +0.4% |
| 3Y | +96.7% | +138.8% | -42.1% | +11.3% |
| All | +96.7% | +134.7% | -38.0% | +11.3% |
Cumulative growth
Daily Returns
Daily percentage return beside IVZ.
Daily Out/Under-Performance
Portfolio return minus IVZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IVZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded IVZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling